United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$139Mraised across 3 rounds since 2014, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
From a historical funding recordSEC filing: $12M sold, first sale Sept 2014
No investor was named in the report.
From a historical funding recordSEC filing: $2.9M sold, first sale Sept 2014
From Caribou Biosciences's own website and the SEC filings it signed: 7 on the team.
On the board, as filediJeffrey G. Long-McGieNatalie R. SacksRobert E. WeisskoffSanthosh G. Palani
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Novartis
National Science Foundation
Janus Henderson Investors
Marc Bell CapitalMaverick Ventures
AbbVieJenny RookeMissing a round, or an investor who was in one? Tell us.
These 2 firms list Caribou Biosciences as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Caribou Biosciences's investors include Novartis, National Science Foundation, Janus Henderson Investors, Marc Bell Capital and Maverick Ventures, and 2 more on record.
Caribou Biosciences has raised $139M across 3 rounds since 2014.
Caribou Biosciences's most recent round was an Undisclosed round of $125M in Jul 2023.
Its most recent round, $125M in Jul 2023, is also its largest on record.
Caribou Biosciences's first round on record, in Mar 2015, was backed by Marc Bell Capital, Novartis and Jenny Rooke.
Caribou Biosciences's latest named round is an Undisclosed round, in Jul 2023.
Caribou Biosciences is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
